These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26451371)

  • 21. Homozygous SLC4A11 mutation in a large Irish CHED2 pedigree.
    Hand CK; McGuire M; Parfrey NA; Murphy CC
    Ophthalmic Genet; 2017; 38(2):148-151. PubMed ID: 27057589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mice with a targeted disruption of Slc4a11 model the progressive corneal changes of congenital hereditary endothelial dystrophy.
    Han SB; Ang HP; Poh R; Chaurasia SS; Peh G; Liu J; Tan DT; Vithana EN; Mehta JS
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6179-89. PubMed ID: 23942972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Throughput Assay Identifies Glafenine as a Corrector for the Folding Defect in Corneal Dystrophy-Causing Mutants of SLC4A11.
    Chiu AM; Mandziuk JJ; Loganathan SK; Alka K; Casey JR
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7739-53. PubMed ID: 26641551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A biochemical framework for SLC4A11, the plasma membrane protein defective in corneal dystrophies.
    Vilas GL; Morgan PE; Loganathan SK; Quon A; Casey JR
    Biochemistry; 2011 Mar; 50(12):2157-69. PubMed ID: 21288032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational spectrum of SLC4A11 in autosomal recessive CHED in Saudi Arabia.
    Aldahmesh MA; Khan AO; Meyer BF; Alkuraya FS
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4142-5. PubMed ID: 19369245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ophthalmic Nonsteroidal Anti-Inflammatory Drugs as a Therapy for Corneal Dystrophies Caused by SLC4A11 Mutation.
    Alka K; Casey JR
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4258-4267. PubMed ID: 30140924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligomerization of SLC4A11 protein and the severity of FECD and CHED2 corneal dystrophies caused by SLC4A11 mutations.
    Vilas GL; Loganathan SK; Quon A; Sundaresan P; Vithana EN; Casey J
    Hum Mutat; 2012 Feb; 33(2):419-28. PubMed ID: 22072594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autosomal recessive CHED associated with novel compound heterozygous mutations in SLC4A11.
    Aldave AJ; Yellore VS; Bourla N; Momi RS; Khan MA; Salem AK; Rayner SA; Glasgow BJ; Kurtz I
    Cornea; 2007 Aug; 26(7):896-900. PubMed ID: 17667634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autosomal recessive corneal endothelial dystrophy (CHED2) is associated with mutations in SLC4A11.
    Jiao X; Sultana A; Garg P; Ramamurthy B; Vemuganti GK; Gangopadhyay N; Hejtmancik JF; Kannabiran C
    J Med Genet; 2007 Jan; 44(1):64-8. PubMed ID: 16825429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Harboyan syndrome: novel SLC4A11 mutation, clinical manifestations, and outcome of corneal transplantation.
    Tananuvat N; Tananuvat R; Chartapisak W; Mahanupab P; Hokierti C; Srikummool M; Kampuansai J; Intachai W; Olsen B; Ketudat Cairns JR; Kantaputra P
    J Hum Genet; 2021 Feb; 66(2):193-203. PubMed ID: 32884076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy.
    Salman M; Verma A; Chaurasia S; Prasad D; Kannabiran C; Singh V; Ramappa M
    Orphanet J Rare Dis; 2022 Sep; 17(1):361. PubMed ID: 36115991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse Slc4a11 expressed in Xenopus oocytes is an ideally selective H+/OH- conductance pathway that is stimulated by rises in intracellular and extracellular pH.
    Myers EJ; Marshall A; Jennings ML; Parker MD
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C945-C959. PubMed ID: 27681179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Missense mutations in the sodium borate cotransporter SLC4A11 cause late-onset Fuchs corneal dystrophy.
    Riazuddin SA; Vithana EN; Seet LF; Liu Y; Al-Saif A; Koh LW; Heng YM; Aung T; Meadows DN; Eghrari AO; Gottsch JD; Katsanis N
    Hum Mutat; 2010 Nov; 31(11):1261-8. PubMed ID: 20848555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of phenotype-genotype correlation of patients expressing mutations in the SLC4A11 gene.
    Mehta JS; Hemadevi B; Vithana EN; Arunkumar J; Srinivasan M; Prajna V; Tan DT; Aung T; Sundaresan P
    Cornea; 2010 Mar; 29(3):302-6. PubMed ID: 20118786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harboyan syndrome with biallelic SLC4A11 pathogenic variants misdiagnosed as congenital CMV infection.
    Loveridge-Easther C; Kiray G; Hull S; Vincent AL
    Ophthalmic Genet; 2022 Oct; 43(5):685-688. PubMed ID: 35672901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autosomal recessive congenital hereditary corneal dystrophy associated with a novel
    Chibani Z; Abid IZ; Söderkvist P; Feki J; Aifa MH
    Br J Ophthalmol; 2022 Feb; 106(2):281-287. PubMed ID: 33879471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel SLC4A11 mutations in patients with recessive congenital hereditary endothelial dystrophy (CHED2). Mutation in brief #958. Online.
    Ramprasad VL; Ebenezer ND; Aung T; Rajagopal R; Yong VH; Tuft SJ; Viswanathan D; El-Ashry MF; Liskova P; Tan DT; Bhattacharya SS; Kumaramanickavel G; Vithana EN
    Hum Mutat; 2007 May; 28(5):522-3. PubMed ID: 17397048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detailed assessment of renal function in a proband with Harboyan syndrome caused by a novel homozygous SLC4A11 nonsense mutation.
    Liskova P; Dudakova L; Tesar V; Bednarova V; Kidorova J; Jirsova K; Davidson AE; Hardcastle AJ
    Ophthalmic Res; 2015; 53(1):30-5. PubMed ID: 25500497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IPSC-Derived Corneal Endothelial-like Cells Act as an Appropriate Model System to Assess the Impact of SLC4A11 Variants on Pre-mRNA Splicing.
    Brejchova K; Dudakova L; Skalicka P; Dobrovolny R; Masek P; Putzova M; Moosajee M; Tuft SJ; Davidson AE; Liskova P
    Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):3084-3090. PubMed ID: 31323090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human SLC4A11-C functions as a DIDS-stimulatable H⁺(OH⁻) permeation pathway: partial correction of R109H mutant transport.
    Kao L; Azimov R; Abuladze N; Newman D; Kurtz I
    Am J Physiol Cell Physiol; 2015 Jan; 308(2):C176-88. PubMed ID: 25394471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.